Pfizer 1Q 1Q Revenues: $10.9 billion (-8%) 1Q Earnings: $2.7 billion (-2%) Comments: U.S. revenues were $5.0 billion (-10%) and International revenues were $5.9 billion (-7%). Foreign exchange unfavorably impacted revenues by approximately 5%. Results were impacted by loss of U.S. exclusivity for Zyrtec in January 2008 and Camptosar in February 2008, revenue declines for Lipitor and Chantix, as well as costs incurred in connection with the pending Wyeth acquisition. Oncology revenues w...